Effect of a Probiotic or Postbiotic on Gut Microbiome During Antibiotic Treatment
← catalyst calendarNCT07594860 · readout in 285 d
Sponsored by The Archer-Daniels-Midland Company (industry) · ADM — their whole pipeline →. With NEXT CRO.
Phase
Not applicable
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · Triple · Prevention
Enrollment
126estimated
Sites
1
Country
Greece
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-06-01 | estimated | When the study began enrolling |
| Primary completion | 2027-05-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-05-31 | estimated | The whole study's end, after follow-up |
| First posted | 2026-05-19 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Microbiome
Interventions
- Dietary supplement: Probiotic
- Dietary supplement: Postbiotic
- Dietary supplement: Placebo
Primary outcome
what the primary-completion date above is the date OFChanges in gut microbiome composition between baseline and day 14 as compared to placebo.
measured Day 0 and Day 14
Permalink · ADM's whole pipeline · Catalyst calendar · Every registered study · What changed